This week in Washington IP news, following the federal holiday to celebrate Martin Luther King, Jr. Day Congress is not in session, but there are still some interesting events to put on your calendar, including the all-day listening session on United States Patent and Trademark Office (USPTO)-U.S. Food & Drug Administration collaboration on Thursday; a panel discussion at the American Enterprise Institute about the near-term future for financial markets; and a discussion with IP experts at the USPTO about IP protection in China.
Recent Posts
- After Loper Bright, the USPTO Should Reopen the Comment Period for FY 2025-2029 Patent Fees
- Dissecting the USPTO’s Update to Eligibility Guidance for AI Inventions
- Other Barks & Bites for Friday, October 4: Meta Hit with Class Action Copyright Infringement Lawsuit; Industry Leaders Ask for Clarification on Third-Party Litigation; EUIPO Applauds German Court Ruling on Misleading Invoices
- Patently Strategic Podcast: ITC Proofing Portfolios
- USPTO Says Order Terminating More than 3,000 Applications for Fraudulent Signatures is a Warning for Practitioners